staceywhite, Author at European Medical Journal - Page 53 of 195

Review of the European Society for Medical Oncology (ESMO) Congress 2023

RENOWNED for its art, history, and above all, churros, Madrid, Spain, saw thousands flock to the city this October for the European Society…

Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors

The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…

Dressing for Paediatric Hypospadias

The optimal dressing is still unclear, despite hypospadias being one of the most prevalent surgical operations. Children’s dressing for…

Pregnancy After Breast Cancer: Is it Safe?

AN INSIGHTFUL session featuring a debate analysed the safety and feasibility of pregnancy amongst survivors of early breast cancer (EBC) at…

Current and Upcoming Treatment Strategies After CDK4/6 Inhibitors for Patients With ER+/HER2- Advanced Breast Cancer

The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…

The Hallmarks of Cancer in 2023

CURRENT cancer hallmarks, their capabilities, and potential targeted therapies were the focus of the presentation given by Douglas Hanahan…

Results of the ATLANTIS Trial: A Randomised Controlled Trial of Amitriptyline as Second-Line Treatment for IBS in Primary Care

This webinar explores the ATLANTIS trial, a randomised controlled trial investigating amitriptyline as second-line treatment for irritable…

Food Insecurity Among Patients with Cancer

This paper explores the overlooked influence of food insecurity on cancer care, its correlation with malnutrition and poor patient…

Challenges and Opportunities in Lyssavirus Detection, Prevention, and Control

Watch our latest webinar, which explores the current global landscape relating to rabies. Expert Charles Rupprecht, Auburn University…

Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2- advanced breast cancer

The presentation focused on advancing the treatment of oestrogen-receptor positive (ER+) human epidermal growth factor receptor…